Document Detail


A pilot randomized trial of pentoxifylline for the reduction of periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention.
MedLine Citation:
PMID:  25475357     Owner:  NLM     Status:  Publisher    
Abstract/OtherAbstract:
PURPOSE: Periprocedural myocardial injury (PMI) following percutaneous coronary intervention (PCI) has received great attention due to its significant association with mortality and morbidity. Accordingly, cardioprotection during PCI is one of the important therapeutic concerns. Regarding the potential cardiovascular benefits of pentoxifylline this study was performed to evaluate whether the pretreatment pentoxifylline could reduce PMI in patients who are undergoing elective PCI.
METHODS: A randomized clinical trial on 85 patients undergoing elective PCI was performed. The intervention group (n = 41) received 1200 mg pentoxifylline in divided doses plus the standard treatment before PCI, while the control group (n = 44) received the standard treatment. For assessing myocardial damage during PCI, the levels of CK-MB and troponin-I were measured at baseline, 8, and 24 h after the procedure. Then, patients were followed up for a 1-month period regarding the major adverse cardiac effect.
RESULTS: Comparing with the control group, no significant change of CK-MB at 8 (p = 0.315) and 24 h (p = 0.896) after PCI was documented in pentoxifylline group. Similarly, no significant change was found in troponin-I at 8 (p = 0.141) and 24 h (p = 0.256) after PCI.
CONCLUSIONS: This study could not support the pretreatment with pentoxifylline in the prevention of PMI in patients undergoing elective PCI. However, the trend was toward the potential benefit of pentoxifylline.
Authors:
Naser Aslanabadi; Hamid Reza Shirzadi; Hossein Asghari-Soufi; Samaneh Dousti; Samad Ghaffari; Bahram Sohrabi; Simin Ozar Mashayekhi; Hadi Hamishehkar; Taher Entezari-Maleki
Related Documents :
2426667 - Failure to sense p waves during ddd pacing.
25481777 - Thrombus aspiration for reperfusion in myocardial infarction: predictors and clinical i...
25288517 - Clinical profile and impact of family history of premature coronary artery disease on c...
25152777 - Acute coronary syndrome in the young: clinical characteristics, risk factors and progno...
3378447 - Early rehabilitation of patients in the convalescence phase after myocardial infarction...
9774187 - Ischemic preconditioning in isolated perfused mouse heart: reduction in infarct size wi...
Publication Detail:
Type:  JOURNAL ARTICLE     Date:  2014-12-5
Journal Detail:
Title:  European journal of clinical pharmacology     Volume:  -     ISSN:  1432-1041     ISO Abbreviation:  Eur. J. Clin. Pharmacol.     Publication Date:  2014 Dec 
Date Detail:
Created Date:  2014-12-5     Completed Date:  -     Revised Date:  2014-12-6    
Medline Journal Info:
Nlm Unique ID:  1256165     Medline TA:  Eur J Clin Pharmacol     Country:  -    
Other Details:
Languages:  ENG     Pagination:  -     Citation Subset:  -    
Export Citation:
APA/MLA Format     Download EndNote     Download BibTex
MeSH Terms
Descriptor/Qualifier:

From MEDLINE®/PubMed®, a database of the U.S. National Library of Medicine


Previous Document:  Distinguishing intrinsic from extrinsic factors underlying firing rate saturation in human motor uni...
Next Document:  Increased bioavailability of phenylephrine by co-administration of acetaminophen: results of four op...